ÂÜÀòÂÒÂ×

Zhonghua Liu has worked in the biotechnology industry since 2015. From 2015 to 2016, they were the Manager of Assay Development at PathSensors, Inc., where they led multiple projects to develop cell-based and immunological assays for the detection of bacteria, viruses, and other pathological microorganisms. From 2016 to 2017, they were a Senior Scientist at MilliporeSigma, where they led assay validation projects across multiple disciplines including gene therapy, cell therapy, immunotherapy, and monoclonal antibody drugs. From 2021 to 2022, they were a Senior Manager of Analytical Platforms at uniQure, where they built and led a team to ensure on time delivery of analytical platform packages and served as Interim Site Lead. Currently, they are the Director of Analytical Development and QC at Vita Therapeutics.

Zhonghua Liu holds a PhD in Biochemistry from Kansas State University and a Bachelor's Degree in Molecular Biology from Jilin University.